Unresolved issues and controversies in purinergic signalling
1Autonomic Neuroscience Centre, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK. g.burnstock@ucl.ac.uk
The Journal of Physiology
|May 24, 2008
Summary
This review highlights unresolved questions in purinergic signaling, focusing on ATP transport, receptor interactions, and P2X receptor functions in pain and inflammation. Future research should explore evolution, development, and therapeutic strategies for purinergic signaling.
Area of Science:
- Purinergic signaling
- Neuroscience
- Pharmacology
Background:
- The field of purinergic signaling is rapidly expanding.
- Several key areas remain controversial or unresolved, necessitating further investigation.
Purpose of the Study:
- To highlight controversial and unresolved areas in purinergic signaling.
- To discuss desirable future research directions in the field.
Main Methods:
- Review of current literature on purinergic signaling.
- Identification of key controversies and research gaps.
Main Results:
- Mechanisms of ATP transport across membranes are debated.
- The interaction of multiple purine and pyrimidine receptors on single cells requires clarification.
- The role of P2X(4) and P2X(7) receptor antagonists in neuropathic and inflammatory pain is complex.
- The multifaceted actions mediated by P2X(7) receptors warrant further study.
Conclusions:
- Further research is needed to elucidate ATP transport mechanisms.
- Understanding receptor interactions and P2X(7) receptor functions is crucial.
- Comparative evolutionary studies, developmental roles, and therapeutic strategies are important future research avenues.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...